Therapeutic Classification: hemostatic agents
Pharmacologic Classification: antifibrinolytics, plasminogen inactivators
Absorption: IV administration results in complete bioavailability; 45% absorbed following oral administration.
Distribution: Penetrates readily into joint fluid and synovial membranes.
Metabolism/Excretion: 95% excreted unchanged in urine.
Half-life: IV: 2 hr (↑ in renal impairment); Oral: 11 hr.
Contraindicated in:
Use Cautiously in:
CV: hypotension, thromboembolism.
EENT: visual abnormalities.
GI: diarrhea, nausea, vomiting.
MS: pain.
Neuro: headache, dizziness, SEIZURES.
Misc: PO: ANAPHYLAXIS .
Drug-Drug:
Renal Impairment
Renal Impairment
(Generic available)
IV Administration:
NDC Code*